Search

Search Constraints

You searched for: Author/Creator Humala, Nelson

Search Results

1. Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial. Issue 11 (November 2022)

2. CTNI-25. PHASE IB CLINICAL TRIAL OF CHRONIC CONVECTION-ENHANCED DELIVERY OF TOPOTECAN FOR RECURRENT GLIOBLASTOMA. (9th November 2020)

3. Dietary Alteration of Cysteine and Methionine Sensitizes Gliomas to Ferroptosis Inducing Agents and Radiation. (16th November 2020)

5. ETMM-04. AURKA INHIBITION REPROGRAMS METABOLISM AND IS SYNTHETICALLY LETHAL WITH FATTY ACID OXIDATION INHIBITION IN GLIOBLASTOMA MODEL SYSTEMS. (25th March 2021)

7. Ex Vivo Modeling of Malignant Pineal Tumors Using Viral Transformation of Transgenic Murine Pineal Gland Cultures. (16th November 2020)

8. TAMI-33. AURKA INHIBITION REPROGRAMS METABOLISM AND IS SYNTHETICALLY LETHAL WITH FATTY ACID OXIDATION INHIBITION IN GLIOBLASTOMA. (9th November 2020)

9. TAMI-57. INDUCTION OF FERROPTOSIS PROMOTES IMMUNOGENIC CELL DEATH AND ACTIVATION OF THE IMMUNE MICROENVIRONMENT IN GLIOMA. (12th November 2021)

10. TAMI-70. METABOLIC VULNERABILITY TO GPX4 INHIBITION AND FERROPTOSIS OF QUIESCENT ASTROCYTE-LIKE GLIOMA CELL POPULATIONS. (12th November 2021)